Kolexia
Camus Vincent
Psychiatrie
Centre hospitalier de Tours
Tours, France
148 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Atrophie Démence Maladies neuro-inflammatoires COVID-19 Tumeurs du sein Maladie chronique Inflammation Perte de poids

Industries

A+A
2 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
Journal of affective disorders   20 novembre 2023
Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry   19 octobre 2023
Improvement of hedonic perception of odors as a marker of treatment response to Escitalopram - Olfactory changes through an open-label antidepressant trial.
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)   17 septembre 2023
Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study.
Molecular psychiatry   17 août 2023
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort.
Brain sciences   24 juillet 2023
Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.
Progress in neuro-psychopharmacology & biological psychiatry   27 avril 2023
InflaDep: Cerebral Neuroinflammation During Major Depressive Episode: Multicentric Comparative Study.
Essai Clinique (CHU Toulouse)   29 mars 2023
RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode
Essai Clinique (Mapreg)   01 mars 2023
Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markers.
Journal of affective disorders   24 février 2023
Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure.
British journal of clinical pharmacology   29 décembre 2022